Apollo Hospitals gets NSE nod on composite demerger scheme

Strategic Transactions View source PDF Explain this filing

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹7075.00

prior close

₹7117.50

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.1%+1.6% vs market

Hospital peers, median of 22sector+0.2%+1.2% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty 100 and 1.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.2

15m

+0.4

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4-0.1+1.6+0.2+1.2

Next day

+1.2-0.5+1.7-0.9+2.1

+0.1-0.9+1.0-1.5+1.6

-1.3-0.9-0.4-1.9+0.6

-0.5-0.1-0.4-1.1+0.6

+0.6+0.0+0.5+0.2+0.4

+0.2+0.5-0.4+0.5-0.3

15d

+2.2-1.6+3.8-4.8+7.0

-3.6-3.8+0.2-11.2+7.6

+9.1-2.2+11.4-11.9+21.0

+5.1-12.0+17.1-16.1+21.2

UpDownMarket · Nifty 100Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE gave a no-objection letter on December 23, 2025, for Apollo Hospitals' proposed composite scheme of arrangement. The scheme involves demerging an identified business undertaking of Apollo Hospitals into Apollo Healthtech Limited, and merging Apollo Healthco and Keimed Private into Apollo Healthtech. Apollo Healthtech will be newly listed on NSE and BSE. Competition Commission of India had approved the transactions in September 2025. Scheme still requires NCLT filing plus shareholder and creditor approvals.

Likely market impact

Progress toward restructuring and separate listing of Apollo Healthtech; value unlock potential but subject to further approvals.